6.03
0.99%
-0.06
Handel nachbörslich:
6.06
0.03
+0.50%
Finanzdaten der Recursion Pharmaceuticals Inc-Aktie (RXRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
26.66%
13.79
|
10.89 | 10.53 | 11.02 | 12.13 |
Cost Of Revenue |
13.00%
11.17
|
9.881 | 10.88 | 9.382 | 12.45 |
Gross Profit |
160.20%
2.628
|
1.01 | -0.344 | 1.635 | -0.314 |
Operating Expenses
|
0.97%
98.97
|
99.94 | 99.21 | 83.35 | 69.55 |
Interest Income/Expense |
23.08%
0.02
|
0.026 | 0.025 | 0.026 | 0.019 |
Benefits Costs and Expenses |
15.30%
105.95
|
91.89 | 110.08 | 92.73 | 82.00 |
Costs And Expenses |
0.29%
110.13
|
109.82 | 110.08 | 92.73 | 82.00 |
Operating Income/Loss |
2.62%
-96.34
|
-98.93 | -99.55 | -81.72 | -69.86 |
Nonoperating Income/Loss |
123.72%
4.188
|
1.872 | 6.533 | 4.989 | 4.538 |
Income/Loss From Continuing Operations Before Tax |
13.77%
-92.15
|
-81.00 | -99.55 | -81.72 | -69.86 |
Income Tax Expense/Benefit |
80.82%
-0.779
|
-4.062 | - | - | - |
Income/Loss From Continuing Operations After Tax |
1.75%
-91.37
|
-93.00 | -93.02 | -76.73 | -65.33 |
Net Income/Loss
|
1.75%
-91.37
|
-93.00 | -93.02 | -76.73 | -65.33 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,855%
236.02
|
4.7631 | 214.33 | 201.42 | 191.62 |
Diluted Average Shares |
4,855%
236.02
|
4.7631 | 214.33 | 201.42 | 191.62 |
Basic Earnings Per Share |
7.14%
-0.39
|
-0.42 | -0.43 | -0.38 | -0.34 |
Diluted Earnings Per Share |
7.14%
-0.39
|
-0.42 | -0.43 | -0.38 | -0.34 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):